| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Forma Therapeutics Holdings, Inc. | SVP, Chief Scientific Officer | Common Stock | 41,469 | $209,418 | $5.05 | 28 Feb 2022 | Direct |
| Forma Therapeutics Holdings, Inc. | SVP, Chief Scientific Officer | Stock Option (Right to Buy) | 37,500 | 28 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322008644-cook-david-n-2022-02-28 | Forma Therapeutics Holdings, Inc. | 28 Feb 2022 | 2 | $0 | 4 | SVP, Chief Scientific Officer | 02 Mar 2022, 16:14 |
| /report/000089924322007924-cook-david-n-2022-02-23 | Forma Therapeutics Holdings, Inc. | 23 Feb 2022 | 1 | -$34,524 | 4 | SVP, Chief Scientific Officer | 25 Feb 2022, 16:09 |